Min-Ho Kim Lab:Lab Members: Difference between revisions
Min-Ho Kim (talk | contribs) No edit summary |
Min-Ho Kim (talk | contribs) No edit summary |
||
| Line 68: | Line 68: | ||
<h2>Alumni</h2> | <h2>Alumni</h2> | ||
<font size=3> | <font size=3> | ||
* '''Bing Yu''', Research Associate, May 2013-August 2020. | * '''Eric Dyne''', Ph.D, August 2018-May 2021, Currently Postdoc at NIH NINDS. | ||
* '''Bing Yu''', Research Associate, May 2013-August 2020. Currently at Alliance Pharma. | |||
* '''[https://www.kent.edu/cas/news/2020-phd-graduate-learned-how-cultivate-meat-lab-while-kent-state Jess Krieger]''', Ph.D, August 2017-December 2020 , Co-founder of Artemys Foods, Currently CEO and co-founder of Ohayo Valley. | * '''[https://www.kent.edu/cas/news/2020-phd-graduate-learned-how-cultivate-meat-lab-while-kent-state Jess Krieger]''', Ph.D, August 2017-December 2020 , Co-founder of Artemys Foods, Currently CEO and co-founder of Ohayo Valley. | ||
* '''Ronghui Song''', Ph.D, August 2018-May 2020, Currently at Johnson and Johnson. | * '''Ronghui Song''', Ph.D, August 2018-May 2020, Currently at Johnson and Johnson. | ||
Revision as of 00:07, 18 August 2021
Min-Ho Kim, Ph.D.,Principal Investigator
Associate professor, Dept. of Biological Sciences, Kent State University Email: mkim15@kent.edu / Phone: 330-672-1445 Prof. Kim's department profile
|
Graduate students
|
Eric Dyne, Ph.D candidate in School of Biomedical SciencesEric has studied neurodegeneration since the beginning of his Ph.D. program after finishing his Bachelor's degree in Biological Sciences at Kent State University. The focus of his research is to develop nanotherapeutics for targeting toxic Aβ plaques and microglia via minimally invasive manner towards the treatment of AD/ADRD. |
Alhussain Ojaym, MSc, Ph.D program in School of Biomedical SciencesHussain joined Kim lab in January 2019. He is currently in the Ph.D program in the school of Biomedical Sciences at Kent State University. He has B.Sc. in Medical Laboratory and MSc. in Biomedical Sciences- specialization in Medical & Molecular Immunology. The focus of his research is to develop nanotherapeutics for targeting macrophages towards the resolution of biofilm infections.
|
Alumni
|
Undergraduate students
|
Kim Lab lunch-Novemver 2017